Bivirkningsprofilen i kliniske afprøvninger hos patienter med benign prostatahyperplasi svarede til den, der ses ved hypertension.
The majority of the adverse reactions were transient The adverse reaction profile in clinical trials with patients with benign prostatic hyperplasia corresponded to the one seen in hypertension.